Procter & Gamble insider Form 4: 189 RSUs awarded to director
Rhea-AI Filing Summary
Craig Arnold, a director of Procter & Gamble Co. (PG), was granted 189 restricted stock units (RSUs) on 09/09/2025. The award is under The Procter & Gamble 2019 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional RSUs. The filing reports 703.4862 shares (or RSU-equivalent) beneficially owned by the reporting person after the transaction. The Form 4 was signed by an attorney-in-fact on 09/10/2025 and discloses this non-derivative equity award.
Positive
- 189 restricted stock units awarded to a director, aligning management and shareholder interests
- Dividend equivalents credited as additional RSUs, enhancing the award's value
Negative
- None.
Insights
TL;DR: Routine director equity grant of 189 RSUs, modest in scale and consistent with compensation alignment practices.
The Form 4 documents a non-derivative award of 189 restricted stock units to a company director on 09/09/2025 under the 2019 stock plan, with dividend equivalents included. This is a standard compensation mechanism to align director incentives with shareholder value without indicating any change in control or material corporate event. The post-transaction beneficial ownership reported as 703.4862 (RSU-equivalent) should be interpreted as the director's total reported holdings per the filing.
TL;DR: Director grant appears procedural and consistent with typical governance practice; disclosure is timely and complete.
The filing shows an equity compensation award for a director recorded on Form 4 and executed via attorney-in-fact. Granting RSUs to directors is a routine governance practice to promote long-term alignment. The inclusion of dividend equivalents is standard. There is no indication in the filing of amendments, option exercises, or derivative transactions that would raise governance concerns.